ZAI LAB SHANGHAI CO LTD has a total of 11 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property Organization), China and EPO (European Patent Office). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are POLYCHIP PHARMACEUTICALS PTY, SHANGHAI GL POLYPEPTIDE CO LTD and CHEMICAL & BIOPHARMACEUTICAL LABORATORIES OF PATRAS S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | China | 3 | |
#3 | EPO (European Patent Office) | 1 | |
#4 | Israel | 1 | |
#5 | Republic of Korea | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Organic chemistry methods | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Therapeutic chemical compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Li Jing | 5 |
#2 | Wang Tianhao | 5 |
#3 | Li Shou | 5 |
#4 | Gao Honghai | 4 |
#5 | Lin Yuan | 3 |
#6 | Wan Bing | 3 |
#7 | Li Hong | 3 |
#8 | Fang Xu | 3 |
#9 | Qi Shali | 3 |
#10 | Yan James S | 2 |
Publication | Filing date | Title |
---|---|---|
WO2020114480A1 | Anti-claudin antibodies and uses thereof | |
CN111253486A | anti-PD-1 antibodies and uses thereof | |
KR20200056468A | Method for preparing intermediates for synthesizing antitumor drug niraparib and intermediates | |
WO2018137705A1 | Cd47 antigen binding unit and uses thereof |